|
MechanismIntercellular adhesion molecule inhibitors [+1] |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Lipid Sciences, Inc.
0 Patents (Medical) associated with Lipid Sciences, Inc.
100 Deals associated with Lipid Sciences, Inc.
100 Translational Medicine associated with Lipid Sciences, Inc.